Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

Apr 11, 2018

SELL
$59.92 - $68.98 $197,975 - $227,909
-3,304 Closed
0 $0
Q4 2017

Feb 22, 2018

BUY
$59.94 - $65.35 $198,041 - $215,916
3,304
3,304 $211,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ackerman Capital Advisors, LLC Portfolio

Follow Ackerman Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ackerman Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ackerman Capital Advisors, LLC with notifications on news.